Skip to main content
. Author manuscript; available in PMC: 2022 Aug 10.
Published in final edited form as: J Rheumatol. 2022 Feb 15;49(6):592–597. doi: 10.3899/jrheum.210952

Figure 1. Distinct plasma microbiome from gut microbiome.

Figure 1.

(A) Alpha diversity measured using Simpson and Shannon indices by site and patient status. (B) Principal coordinates analysis (PCoA) of beta diversity grouped by site and patient status. Median percentages of relative abundance at the phylum and genus levels in gut and plasma from healthy controls (C) and SLE patients (D). *, P < 0.05; **, P < 0.01; ***, P < 0.001.